Chronic naltrexone suppresses platelet aggregation induced by adrenaline and 5-hydroxytryptamine in former heroin addicts
Authors:
- 1 June 1988
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 73 (2) , 157-160
Abstract
Naltrexone, an opioid receptor antagonist, is used as an adjunct in the treatment of opiate addiction. In former heroin addicts, long-term treatment with naltrexone (350 mg/week for 5 months) resulted in suppression of adrenaline and 5-hydroxytryptamine (5-HT)-induced platelet aggregation. The results demonstrate that sustained blockade of opioid receptors can impair the functional expression of α2-adrenoceptors and 5-HT2 receptors in human platelets. These findings may have negative clinical implications in the treatment of opiate addiction with naltrexone.Keywords
This publication has 11 references indexed in Scilit:
- Blockade of ?2-adrenoceptors permits the operation of otherwise silent opioid ?-receptors at the sympathetic axons of rabbit jejunal arteriesNaunyn-Schmiedeberg's Archives of Pharmacology, 1986
- Activation of presynaptic ?2-adrenoceptors attenuates the inhibitory effect of ?-opioid receptor agonists on noradrenaline release from brain slicesNaunyn-Schmiedeberg's Archives of Pharmacology, 1986
- Heroin increases the density and sensitivity of platelet ?2-adrenoceptors in human addictsPsychopharmacology, 1986
- Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatmentLife Sciences, 1985
- Evidence for functional 5-HT2 receptor sites on human blood plateletsBiochemical Pharmacology, 1984
- Naltrexone: Its clinical utility.1984
- Opiate receptors on lymphocytes and platelets in manClinical Immunology and Immunopathology, 1983
- Naltrexone-induced opiate receptor supersensitivityBrain Research, 1982
- Do human platelets have opiate receptors?Nature, 1980
- INTERACTION OF SELECTIVE α‐ADRENOCEPTOR AGONISTS AND ANTAGONISTS WITH HUMAN AND RABBIT BLOOD PLATELETSBritish Journal of Pharmacology, 1980